How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Device Testing Services Market
- By Testing Type: Biocompatibility Testing, Electrical Safety Testing, Mechanical Testing, Sterilization Validation, Software Validation, Performance Testing
- By Device Class: Class I Medical Devices, Class II Medical Devices, Class III Medical Devices
- By End-User: Medical Device Manufacturers, Contract Research Organizations (CROs), Regulatory Bodies, Hospitals and Clinics
- By Testing Methodology: In Vitro Testing, In Vivo Testing, Ex Vivo Testing, Computational Modeling and Simulation
- By Regulatory Compliance: FDA Compliance Testing, ISO 13485 Compliance Testing, CE Marking Testing, IEC 60601 Compliance Testing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Biocompatibility Testing leads By Testing Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Medical Device Testing Services Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Testing Type 6
Device Class 3
End-User 4
Testing Methodology 4
Regulatory Compliance 4
Companies profiled
Eurofins Scientific
SGS SA
Intertek Group plc
TÜV SÜD
Bureau Veritas
UL LLC
NSF International
NAMSA (North American Science Associates)
Covance Inc. (LabCorp)
Pace Analytical Services
Medpace Holdings Inc.
ICON plc
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →SGS SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Intertek Group plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →TÜV SÜD
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bureau Veritas
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →UL LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →NSF International
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →NAMSA (North American Science Associates)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Covance Inc. (LabCorp)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Pace Analytical Services
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Medpace Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →ICON plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Charles River Laboratories International Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →QPS Holdings
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →WuXi AppTec
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,888M by 2033 · 8.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Biocompatibility Testing36.3
- Electrical Safety Testing12.4
- Mechanical Testing15.9
- Sterilization Validation19.1
- Software Validation8.9
- Performance Testing7.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$833.7M → $1,680M · 9.2%
Europe$581.1M → $1,231M · 9.8%
Asia Pacific$530.5M → $947.6M · 7.5%
Latin America$328.4M → $601.6M · 7.9%
Middle East and Africa$252.6M → $513.2M · 9.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.552026
8.562027
8.582028
8.582029
8.602030
8.612031
8.632032
8.632033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Eurofins Scientific14.9
- SGS SA27.0
- Intertek Group plc4.1
- TÜV SÜD6.9
- Bureau Veritas7.3
- UL LLC11.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Testing Type16.4%
Device Class18.1%
End-User26.8%
Testing Methodology10.7%
Regulatory Compliance28.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe24.7
- Asia Pacific19.1
- Latin America12.1
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Eurofins Scientific | 94 | 94 | 87 | 98 | 84 | 88 | 91 |
| SGS SA | 89 | 82 | 81 | 69 | 79 | 87 | 81 |
| Intertek Group plc | 79 | 85 | 86 | 73 | 73 | 75 | 79 |
| TÜV SÜD | 66 | 63 | 63 | 77 | 77 | 79 | 71 |
| Bureau Veritas | 60 | 53 | 72 | 60 | 54 | 64 | 61 |
| UL LLC | 65 | 66 | 61 | 46 | 52 | 53 | 57 |
| NSF International | 46 | 64 | 53 | 41 | 58 | 56 | 53 |
| NAMSA (North American Science Associates) | 60 | 40 | 38 | 40 | 50 | 60 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Eurofins Scientific
- SGS SA
- Intertek Group plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Eurofins Scientific | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| SGS SA | ◐ | ◐ | ✓ | − | ✓ | ◐ |
| Intertek Group plc | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| TÜV SÜD | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Bureau Veritas | ◐ | − | ◐ | − | − | ◐ |
| UL LLC | − | ◐ | ◐ | − | ◐ | − |
| NSF International | ◐ | − | − | − | ◐ | − |
| NAMSA (North American Science Associates) | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Eurofins Scientific91
2SGS SA81
3Intertek Group plc79
4TÜV SÜD71
5Bureau Veritas61
6UL LLC57
7NSF International53
8NAMSA (North American Science Associates)48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Eurofins ScientificSGS SAIntertek Group plc
Challenger1
Strong scale, closing on the leaders.
TÜV SÜD
Contender2
Focused players with pockets of strength.
Bureau VeritasUL LLC
Niche2
Specialists in a single segment or region.
NSF InternationalNAMSA (North American Science Associates)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Testing Type in North America, then scale across Medical Device Testing Services Market — a $356M beachhead inside a $5.49B market.
Beachhead (SOM)$356Mobtainable near-term
Serviceable (SAM)$1.98Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Biocompatibility Testing
Best fit — highest urgency & budget in Testing Type.
Economic buyer75 fit
Electrical Safety Testing
Strong fit — clear ROI and a fast path to value.
End user68 fit
Mechanical Testing
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Testing Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Device Class & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Testing Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Device Testing Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation12%
Closed-won7%
$9.8KCAC
$43KLTV
4.4:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Device Testing Services Market is a durable-growth opportunity — $1.57B by 2033, compounding at 9.6%.
TAM · 2025$750Mtoday
TAM · 2033$1.57Bforecast
CAGR9.6%2027–2033
Cumulative$10.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.57BTotal addressable market
SAM$607MServiceable available market
SOM$106MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.6% CAGR
Demand compounds through 2033, outpacing GDP across Testing Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Testing Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.57BLarge & growingTAM by 2033 at 9.6% CAGR
$607MServiceable nowreachable with today’s model
$106MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.22BBear6.3% CAGR
$1.57BBase9.6% CAGR
$2.00BBull12.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Device Class optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Device Testing Services Market — a $2.19B market by 2033. Plan: grow share from 6.8% to 11.2%.
Market size · 2033$2.19Btotal addressable
Market CAGR3.8%2027–2033
Target share11.2%from 6.8% today
Revenue ambition$245Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.8% | 11.2% | Behind |
| Revenue | $153M | $245M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.0% | 42.8% | Behind |
| Customer retention | 88.3% | 95.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Testing Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Device Class capability
A defensible second engine — invest in Device Class to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Testing Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Device Class
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $36M capacity & capability investment
- Greenlight bolt-on M&A in Device Class
- Authorise North America expansion plan
- Fund R&D program for Testing Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Device Testing Services Market conversation — a $1.84B market you can size, segment and defend in minutes.
Market size · 2033$1.84Btotal opportunity
Growth9.3%CAGR to 2033
Addressable buyers1,731+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Testing Type
Goal Grow share in Testing Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 3 mopayback period
$77K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Eurofins ScientificSGS SAIntertek Group plcTÜV SÜDBureau VeritasUL LLCNSF InternationalNAMSA (North American Science Associates)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Device Testing Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Device Testing Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Liquid Handling Technology Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportMelanoma Therapeutics Market
Market size, share, segmentation and regional forecast.
$876M market · 2025 base year
View reportThalassemia Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportIntegrated Cardiac Safety Service Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportMedical Robotic Systems Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportIntegrated Capillary Blood Collection System Market
Market size, share, segmentation and regional forecast.
$668M market · 2025 base year
View reportSingle-Cell Genome Sequencing Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportIntegrated Cancer Care Management Service Platform Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportRare Hemophilia Factors Market
Market size, share, segmentation and regional forecast.
$404M market · 2025 base year
View reportPoultry Diagnostics Market
Market size, share, segmentation and regional forecast.
$790M market · 2025 base year
View reportHealthcare Biometric Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportIntegrated Blood Bank Information System Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.